Five Things Physicians and Patients Should
... to monitor for a cancer recurrence in asymptomatic patients who have finished initial treatment to eliminate the cancer unless there is high-level evidence that such imaging will change the outcome. • PET and PET-CT are used to diagnose, stage and monitor how well treatment is working. Available ev ...
... to monitor for a cancer recurrence in asymptomatic patients who have finished initial treatment to eliminate the cancer unless there is high-level evidence that such imaging will change the outcome. • PET and PET-CT are used to diagnose, stage and monitor how well treatment is working. Available ev ...
Highlights from the San Antonio Breast Cancer Symposium
... ceived standard chemotherapy alone (n = 104) or The Austrian Breast and Colorectal Cancer combined with zoledronic acid 4 mg IV every 3 to Study Group (ABCSG)-12 enrolled 1803 pre4 weeks for 6 months (n = 101) prior to surgery. menopausal women with ER+ early breast Patients’ baseline characteristic ...
... ceived standard chemotherapy alone (n = 104) or The Austrian Breast and Colorectal Cancer combined with zoledronic acid 4 mg IV every 3 to Study Group (ABCSG)-12 enrolled 1803 pre4 weeks for 6 months (n = 101) prior to surgery. menopausal women with ER+ early breast Patients’ baseline characteristic ...
Prostate Cancer Patient`s Guide to Hormone Therapy
... men. It is the second leading cause of cancer-related death in men (behind lung cancer). In 2005, it is estimated by the American Cancer Society that 232,090 men in the United States will be diagnosed with this disease and 30,350 men will die as a result of it. Today, greater numbers of men are bein ...
... men. It is the second leading cause of cancer-related death in men (behind lung cancer). In 2005, it is estimated by the American Cancer Society that 232,090 men in the United States will be diagnosed with this disease and 30,350 men will die as a result of it. Today, greater numbers of men are bein ...
Phytoestrogens from Belamcanda chinensis regulate the expression
... and the two purified compounds tectorigenin and irigenin. Recently we reported that established and potential therapeutic targets against prostate cancer are affected by different phytochemicals from B. chinensis. Several of the investigated phytochemicals, mostly isoflavones such as tectorigenin, c ...
... and the two purified compounds tectorigenin and irigenin. Recently we reported that established and potential therapeutic targets against prostate cancer are affected by different phytochemicals from B. chinensis. Several of the investigated phytochemicals, mostly isoflavones such as tectorigenin, c ...
Transrectal high-intensity focused ultrasound for treatment
... proposed (the Stuttgart criteria),17 and we intend to compare the results based on the Phoenix-ASTRO and Stuttgart criteria in a future study. Of the 11 patients in the low- (1 patient), intermediate- (6 patients) and high-risk (4 patients) groups who underwent a second HIFU treatment, two each in t ...
... proposed (the Stuttgart criteria),17 and we intend to compare the results based on the Phoenix-ASTRO and Stuttgart criteria in a future study. Of the 11 patients in the low- (1 patient), intermediate- (6 patients) and high-risk (4 patients) groups who underwent a second HIFU treatment, two each in t ...
2015 ASCO Conference Highlights for PCa Patients: May 29
... • Biochemical recurrence of prostate cancer following prostatectomy (rising PSA levels) could indicate either local or metastatic recurrence. While salvage radiation therapy (SRT) may be sufficient to treat local recurrence, the addition of androgen deprivation therapy (ADT) provides better outcomes ...
... • Biochemical recurrence of prostate cancer following prostatectomy (rising PSA levels) could indicate either local or metastatic recurrence. While salvage radiation therapy (SRT) may be sufficient to treat local recurrence, the addition of androgen deprivation therapy (ADT) provides better outcomes ...
Prostate Cancer - Contra Costa Health Services
... other parts of the body.7 Most prostate cancers are identified early through screening, using the prostate-specific antigen (PSA) test.4 Because many prostate cancers are slow-growing, they may never become life threatening. Screening and treatment do provide benefits for some males who develop pros ...
... other parts of the body.7 Most prostate cancers are identified early through screening, using the prostate-specific antigen (PSA) test.4 Because many prostate cancers are slow-growing, they may never become life threatening. Screening and treatment do provide benefits for some males who develop pros ...
What is multiparametric-MRI of the prostate and why do we need it?
... of the type of patient treated for prostate cancer. Prior to approval in the late 1980s most men presented with high risk disease, within 15 years this had shifted with the majority presenting with low risk, organ confined disease [2]. Given the typically indolent nature of low risk disease, this br ...
... of the type of patient treated for prostate cancer. Prior to approval in the late 1980s most men presented with high risk disease, within 15 years this had shifted with the majority presenting with low risk, organ confined disease [2]. Given the typically indolent nature of low risk disease, this br ...
Colorectal Cancer: Risk Prevention and Diagnosis
... Bowel Cancer: Screening Programme • Benefits • Lowers risk of bowel cancer • Can pick cancer at very early stage and improves outcome of treatment • Can identify conditions which can lead to cancer in future ...
... Bowel Cancer: Screening Programme • Benefits • Lowers risk of bowel cancer • Can pick cancer at very early stage and improves outcome of treatment • Can identify conditions which can lead to cancer in future ...
Does the Extent of Carcinoma in Prostatic Biopsies Predict Prostate
... Egawa et al [25] but not that of King et al [26]. In this case, the use of a cut-off point resulted in a significant result [25], which was not reproduced when data were analyzed as continuous variables [26]. When patients were then stratified into three ...
... Egawa et al [25] but not that of King et al [26]. In this case, the use of a cut-off point resulted in a significant result [25], which was not reproduced when data were analyzed as continuous variables [26]. When patients were then stratified into three ...
picos4 137 KB May 01 2016 09:57:18 AM - e
... comes from several sources. For example, vitamin D receptors are present in prostate cells and 1,25-(OH)2 inhibits cell proliferation (17). In addition, mortality from prostate cancer is lower in sunnier regions of the US, where increased exposure to UV light would plausibly increase synthesis of vi ...
... comes from several sources. For example, vitamin D receptors are present in prostate cells and 1,25-(OH)2 inhibits cell proliferation (17). In addition, mortality from prostate cancer is lower in sunnier regions of the US, where increased exposure to UV light would plausibly increase synthesis of vi ...
Quantitative promoter methylation differentiates Carcinoma ex
... Background. Potential epigenetic biomarkers for malignant transformation to Carcinoma exPleomorphic Adenoma (Ca ex PSA) have been sought previously with and without specific comparison to the benign variant, Pleomorphic Salivary Adenoma (PSA). Previous analysis has been limited by a non-quantitative ...
... Background. Potential epigenetic biomarkers for malignant transformation to Carcinoma exPleomorphic Adenoma (Ca ex PSA) have been sought previously with and without specific comparison to the benign variant, Pleomorphic Salivary Adenoma (PSA). Previous analysis has been limited by a non-quantitative ...
Men`s Health Library - Mens Health Network
... Total Views: 597 23. Annual Report to the Nation on the Status of Cancer, 1975-2000 REPORT BROKEN LINK National Cancer Institute. Death rates from the 4 most common cancers-lung, breast, prostate, & colorectal-continued to decline in the late 1990s. Screening; treatment; Healthy People 2010; prostat ...
... Total Views: 597 23. Annual Report to the Nation on the Status of Cancer, 1975-2000 REPORT BROKEN LINK National Cancer Institute. Death rates from the 4 most common cancers-lung, breast, prostate, & colorectal-continued to decline in the late 1990s. Screening; treatment; Healthy People 2010; prostat ...
DO TYPE I RECEPTOR TYROSINE KINASES DRIVE HORMONE
... sensitive tumours (107.5(57.5-175.5) vs 50(0-92) p=0.0005). Further, patient phospho AR expression above the median value in hormone refractory tumours had significantly shorter survival from time of biochemical relapse than patients with low (below the median) phospho AR expression (p=0.0076), this ...
... sensitive tumours (107.5(57.5-175.5) vs 50(0-92) p=0.0005). Further, patient phospho AR expression above the median value in hormone refractory tumours had significantly shorter survival from time of biochemical relapse than patients with low (below the median) phospho AR expression (p=0.0076), this ...
